Secretagogin is a novel marker for neuroendocrine differentiation

Neuroendocrinology

Volumn 82, Issue 2, 2005, Pages 121-138

  Birkenkamp Demtröder, Karin ^a   Wagner, Ludwig ^b   Sørensen, Flemming Brandt ^a   Astrup, Lone Bording ^a   Gartner, Wolfgang ^b   Scherübl, Hans ^c   Heine, Bernhard ^c   Christiansen, Peer ^a   Ørntoft, Torben Falck ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF VIENNA   (Austria)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Clinical neuroendocrinology; Immunohistochemistry; Microarray; Molecular neuroendocrinology; Neuroendocrine tumors; Secretagogin

Indexed keywords

BIOLOGICAL MARKER; CHROMOGRANIN A; FK 506 BINDING PROTEIN; NEURON SPECIFIC ENOLASE; PEPTIDE DERIVATIVE; SECRETAGOGIN; SYNAPTOPHYSIN; UNCLASSIFIED DRUG;

ADENOCARCINOMA; ANALYTIC METHOD; ARTICLE; CARCINOID; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOSOL; DIGESTIVE SYSTEM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOHISTOCHEMISTRY; MALE; MUCOSA; NEUROENDOCRINE SYSTEM; NEUROENDOCRINE TUMOR; NEUROSECRETORY CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TISSUE DISTRIBUTION; WESTERN BLOTTING;

ADENOCARCINOMA; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BLOTTING, WESTERN; CALCIUM-BINDING PROTEINS; CARCINOID TUMOR; CELL DIFFERENTIATION; CHROMOGRANIN A; CHROMOGRANINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MICROSCOPY, FLUORESCENCE; MIDDLE AGED; NEOPLASM METASTASIS; NEUROENDOCRINE TUMORS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PEPTIDYLPROLYL ISOMERASE; PHOSPHOPYRUVATE HYDRATASE; SYNAPTOPHYSIN; TACROLIMUS BINDING PROTEINS; TUMOR MARKERS, BIOLOGICAL;

EID: 33644509532     PISSN: 00283835     EISSN: None     Source Type: Journal    
DOI: 10.1159/000091207     Document Type: Article

References (27)

1. Maggard MA, O'Connell JB, Ko CY: Updated population-based review of carcinoid tumors. Ann Surg 2004;240:117-122.
2. Taal BG, Visser O: Epidemiology of neuroendocrine tumours. Neuroendocrinology 2004;80(suppl 1):3-7.
3. Bernick PE, Klimstra DS, Shia J, Minsky B, Saltz L, Shi W, Thaler H, Guillem J, Paty P, Cohen AM, Wong WD: Neuroendocrine carcinomas of the colon and rectum. Dis Colon Rectum 2004;47:163-169.
4. Horiuchi S, Endo T, Shimoji H, Takahashi H, Mitsuuchi M, Yawata A, Mita H, Yoshida M, Arimura Y, Sakamoto H, Itoh F, Hinoda Y, Imai K, Sasaki K, Sato M: Goblet cell carcinoid of the appendix endoscopically diagnosed and examined with p53 immunostaining. J Gastroenterol 1998;33:582-587.
5. Lin BT, Gown AM: Mixed carcinoid and adenocarcinoma of the appendix: report of 4 cases with immunohistochemical studies and a review of the literature. Appl Immunohistochem Mol Morphol 2004;12:271-276.
6. Birkenkamp-Demtroder K, Christensen LL, Olesen SH, Frederiksen CM, Laiho P, Aaltonen LA, Laurberg S, Sorensen FB, Hagemann R, Orntoft TF: Gene expression in colorectal cancer. Cancer Res 2002;62:4352-4363.
7. Taupenot L, Harper KL, O'Connor DT: The chromogranin-secretogranin family. N Engl J Med 2003;348:1134-1149.
8. Rorstad O: Prognostic indicators for carcinoid neuroendocrine tumors of the gastrointestinal tract. J Surg Oncol 2005;89:151-160.
9. 2+-binding protein. J Biol Chem 2000;275:24740-24751.
10. 2+-binding protein. Cereb Cortex 2001;11:1161-1169.
11. Desiderio DM, Zhan X: The human pituitary proteome: the characterization of differentially expressed proteins in an adenoma compared to a control. Cell Mol Biol (Noisy-le-Grand) 2003;49:689-712.
12. Zhan X, Evans CO, Oyesiku NM, Desiderio DM: Proteomics and transcriptomics analyses of secretagogin down-regulation in human non-functional pituitary adenomas. Pituitary 2003;6:189-202.
13. Cras-Meneur C, Inoue H, Zhou Y, Ohsugi M, Bernal-Mizrachi E, Pape D, Clifton SW, Permutt MA: An expression profile of human pancreatic islet mRNAs by serial analysis of gene expression (SAGE). Diabetologia 2004;47:284-299.
14. Solcia E, Klöppel G, Sobin L: International Histological Classification of Endocrine Tumors in Collaboration with Nine Pathologists from Two Countries, ed 2. Berlin, World Health Organization/Springer.
15. Grabowski P, Schonfelder J, Ahnert-Hilger G, Foss HD, Stein H, Berger G, Zeitz M, Scherubl H: Heterogeneous expression of neuroendocrine marker proteins in human undifferentiated carcinoma of the colon and rectum Ann NY Acad Sci 2004;1014:270-274.
16. Kruhoffer M, Jensen JL, Laiho P, Dyrskjot L, Salovaara R, Arango D, Birkenkamp-Demtroder K, Sorensen FB, Christensen LL, Buhl L, Mecklin JP, Jarvinen H, Thykjaer T, Wikman FP, Bech-Knudsen F, Juhola M, Nupponen NN, Laurberg S, Andersen CL, Aaltonen LA, Orntoft TF: Gene expression signatures for colorectal cancer microsatellite status and HNPCC. Br J Cancer 2005;92:2240-2248.
17. Olesen SH, Christensen LL, Sorensen FB, Cabezon T, Laurberg S, Orntoft TF, Birkenkamp-Demtroder K: Human FK506-binding protein 65 is associated with colorectal cancer. Mol Cell Proteomics 2005;4:534-544.
18. Gartner W, Rossbacher J, Zierhut B, Daneva T, Base W, Weissel M, Waldhausl W, Pasternack MS, Wagner L: The ATP-dependent helicase RUVBL1/TIP49a associates with tubulin during mitosis. Cell Motil Cytoskeleton 2003;56:79-93.
19. Zierhut B, Daneva T, Gartner W, Brunnmaier B, Mineva I, Berggard T, Wagner L: Setagin and secretagogin-R22: post-transcriptional modification products of the secretagogin gene. Biochem Biophys Res Commun 2005;329:1193-1199.
20. Soeda J, O'Briain DS, Puri P: Mucosal neuroendocrine cell abnormalities in the colon of patients with Hirschsprung's disease. J Pediatr Surg 1992;27:823-827.
21. Grabowski P, Griss S, Arnold CN, Horsch D, Goke R, Arnold R, Heine B, Stein H, Zeitz M, Scherubl H: Nuclear survivin is a powerful novel prognostic marker in gastroenteropancreatic neuroendocrine tumor disease. Neuroendocrinology 2005;81:1-9.
22. 2+-regulated transcriptional repressor. Nature 1999;398:80-84.
23. Varadhachary GR, Abbrazzese JL, Lenzi R: Diagnostic strategies for unknown primary cancer. Cancer 2004;100:1776-1785.
24. Dennis JL, Oien KA: Hunting the primary: novel strategies for defining the origin of tumours. J Pathol 2005;205:236-247.
25. Erickson LA, Papouchado B, Dimashkieh H, Zhang S, Nakamura N, Lloyd RV: Cdx2 as a marker for neuroendocrine tumors of unknown primary sites. Endocr Pathol 2004;15:247-252.
26. Wiedenmann B: Synaptophysin. A widespread constituent of small neuroendocrine vesicles and a new tool in tumor diagnosis. Acta Oncol 1991;30:435-440.
27. Loy TS, Darkow GV, Quesenberry JT: Immunostaining in the diagnosis of pulmonary neuroendocrine carcinomas. An immunohistochemical study with ultrastructural correlations. Am J Surg Pathol 1995;19:173-182.